Plasma protein biomarkers reflective of the host response in patients developing Intensive Care Unit-acquired pneumonia.

Autor: van Engelen, Tjitske S. R., Reijnders, Tom D. Y., Paling, Fleur P., Bonten, Marc J. M., Timbermont, Leen, Malhotra-Kumar, Surbhi, Kluytmans, Jan A. J. W., Peters-Sengers, Hessel, van der Poll, Tom, Wolkewitz, Martin, Ali, Omar, Ruzin, Alexey, Lammens, Christine, Hullegie, Sebastiaan, Troeman, Darren, van Hout, Denise, Prins, Daniël, Kalyani, Rubana, Eickhoff, Mark, Shoemaker, Kathryn
Zdroj: Critical Care; 7/6/2023, Vol. 27 Issue 1, p1-11, 11p
Abstrakt: Background: Immune suppression has been implicated in the occurrence of pneumonia in critically ill patients. We tested the hypothesis that Intensive Care Unit (ICU)-acquired pneumonia is associated with broad host immune aberrations in the trajectory to pneumonia, encompassing inflammatory, endothelial and coagulation responses. We compared plasma protein biomarkers reflecting the systemic host response in critically ill patients who acquire a new pneumonia (cases) with those who do not (controls). Methods: We performed a nested case–control study in patients undergoing mechanical ventilation at ICU admission with an expected stay of at least 48 h enrolled in 30 hospitals in 11 European countries. Nineteen host response biomarkers reflective of key pathophysiological domains were measured in plasma obtained on study inclusion and day 7, and—in cases—on the day of pneumonia diagnosis. Results: Of 1997 patients, 316 developed pneumonia (15.8%) and 1681 did not (84.2%). Plasma protein biomarker analyses, performed in cases and a randomly selected subgroup of controls (1:2 ratio to cases, n = 632), demonstrated considerable variation across time points and patient groups. Yet, cases showed biomarker concentrations suggestive of enhanced inflammation and a more disturbed endothelial barrier function, both at study enrollment (median 2 days after ICU admission) and in the path to pneumonia diagnosis (median 5 days after ICU admission). Baseline host response biomarker aberrations were most profound in patients who developed pneumonia either shortly (< 5 days, n = 105) or late (> 10 days, n = 68) after ICU admission. Conclusions: Critically ill patients who develop an ICU-acquired pneumonia, compared with those who do not, display alterations in plasma protein biomarker concentrations indicative of stronger proinflammatory, procoagulant and (injurious) endothelial cell responses. Trial registration: ClinicalTrials.gov Identifier: NCT02413242, posted April 9th, 2015. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: